The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

The history of drug therapy for obesity is littered ... Now, the combination of bupropion and naltrexone is being studied for possible weight-loss effects through its synergistic action on ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating headlines today, they have a long list of less successful (and sometimes dangerous) ...

Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents ... of the two component drugs will require careful ...

But it is not necessarily the same thing as cost-saving. And in the case of the latest wave of weight loss drugs, right now at their current prices they are not even cost-effective, let alone cost ...

Encouraged by her weight-loss progress, Breen decided to give another member of this class of drugs, known as GLP-1 agonists, a shot. Eight months after he stopped taking naltrexone, in April 2023 ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...

It’s no wonder then that a newer class of highly-effective weight-loss drugs, known commonly as GLP-1 or incretin treatments have taken the country by storm. Analysts at Morgan Stanley project ...